Bengaluru, India

Subhendu Kumar Mohanty

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Subhendu Kumar Mohanty. Retrieved from https://idiyas.com/inventor/subhendu-kumar-mohanty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Contributions of Subhendu Kumar Mohanty

Introduction

Subhendu Kumar Mohanty is a prominent inventor based in Bengaluru, India. He has made significant strides in the field of pharmaceutical inventions, particularly through his research and development efforts at Merck Sharp & Dohme Corporation. His work highlights the importance of innovation in the medical field, focusing on the treatment and prevention of various diseases.

Latest Patents

Mohanty holds a patent for "Pyrrolidine derived beta 3 adrenergic receptor agonists." This invention encompasses compounds of Formula (I), pharmaceutical compositions derived from these compounds, and methods for their use in the treatment or prevention of diseases affected by the activation of the β3-adrenoceptor. This patent reflects his dedication to advancing therapeutic options in pharmacology.

Career Highlights

Throughout his career, Subhendu has demonstrated a commitment to innovation within the pharmaceutical industry. His contributions at Merck Sharp & Dohme Corporation have positioned him as an influential figure in drug development, particularly in targeting adrenergic receptors for medical applications.

Collaborations

In his research endeavors, Mohanty has collaborated with esteemed colleagues such as Kenneth Jay Barr and Mark E. Scott. These collaborations have fostered an environment of innovation and have led to substantial advancements in their respective areas of expertise, further enhancing the potential impact of their work on public health.

Conclusion

In conclusion, Subhendu Kumar Mohanty exemplifies the spirit of innovation in the pharmaceutical industry. His singular patent and collaborative efforts at Merck Sharp & Dohme Corporation underline his commitment to enhancing therapeutic strategies, showcasing the pivotal role of inventors in advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…